LY-379,268
http://dbpedia.org/resource/LY-379,268 an entity of type: Thing
LY-379,268 is a drug that is used in neuroscience research, which acts as a potent and selective agonist for the group II metabotropic glutamate receptors (mGluR2/3). It is derived from the older mGluR group II agonist eglumegad, and led on to the development of the more potent compound LY-404,039, but is still widely used in research itself. LY-379,268 has sedative, neuroprotective, anti-addictive and anticonvulsant effects in animals, and blocks the effects of PCP and DOI, which has led to research into LY-379,268 and similar compounds as antipsychotic drugs for the treatment of schizophrenia in animals.
rdf:langString
rdf:langString
LY-379,268
xsd:integer
23842966
xsd:integer
1108881709
xsd:integer
7
xsd:integer
191471
xsd:integer
192545
xsd:integer
8373484
xsd:integer
9
xsd:integer
-2
xsd:integer
1
xsd:integer
5
xsd:integer
10197984
rdf:langString
C1[C@]N
xsd:integer
1
rdf:langString
YASVRZWVUGJELU-MDASVERJSA-N
rdf:langString
S96JF4J697
rdf:langString
changed
xsd:integer
416661399
rdf:langString
changed
xsd:integer
160
rdf:langString
LY-379,268 is a drug that is used in neuroscience research, which acts as a potent and selective agonist for the group II metabotropic glutamate receptors (mGluR2/3). It is derived from the older mGluR group II agonist eglumegad, and led on to the development of the more potent compound LY-404,039, but is still widely used in research itself. LY-379,268 has sedative, neuroprotective, anti-addictive and anticonvulsant effects in animals, and blocks the effects of PCP and DOI, which has led to research into LY-379,268 and similar compounds as antipsychotic drugs for the treatment of schizophrenia in animals. There are inconsistent findings about an additional activity as a dopamine D2 receptor partial agonist.
xsd:nonNegativeInteger
9036
xsd:string
191471-52-0
xsd:string
192545
xsd:string
S96JF4J697
xsd:string
10197984